This session addresses complex procedural complications encountered during TAVI, featuring challenging cases such as aortic dissection, multiple valve procedures including redo TAVI in patients with left ventricular assist devices, and structural failures like valve infolding and embolisation. It emphasizes strategic decision-making under critical circumstances to optimize...

This session explores key risk and prognostic factors in ST-elevation myocardial infarction (STEMI), encompassing biomarker-based outcome prediction, the influence of low-density lipoprotein cholesterol on myocardial injury, and thrombotic risk in atrial fibrillation patients undergoing PCI. It further examines gender differences in young STEMI patients, the safety...

This session highlights the pivotal role of imaging in resolving dilemmas during primary percutaneous coronary intervention (PCI). It presents complex cases illustrating challenges such as coronary compression, thrombus burden in large vessels, and culprit lesion identification, including the use of high-definition intravascular ultrasound (HD-IVUS) to reclassify...

This session covers intricate complications involving the left main coronary artery (LMCA), highlighting cases of catheter-induced dissections, challenges in chronic total occlusion (CTO) PCI, and rare scenarios such as stent entrapment and complex re-interventions. Emphasis is placed on the critical utility of intravascular ultrasound (IVUS) and...

Study the case of this 78-year-old male patient to understand why and how HPG may be important when measuring FFR in patients with CAD, as its height may influence the height of different FFR measurements, and, therefore, the patient management.

The data from this study suggest that, from a SoMe perspective, correct Impella orientation is often overlooked, and that Impella malrotation is a common issue in real-world clinical practice, potentially associated with relevant complications. 

Nicola Ryan provides her take on the FULL REVASC trial which was presented at ACC.24 in Atlanta and published Simultaneously in NEJM.

The FULL REVASC trial is a multicentre registry-based randomised control trial comparing FFR-guided complete revascularisation of non-culprit lesions versus culprit lesion PCI alone in patients presenting...